Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and Immunogenicity of a New Inactivated Polio Vaccine Made From Sabin Strains: A Randomized, Double-Blind, Active-Controlled, Phase 2/3 Seamless Study.
Capeding MR, Gomez-Go GD, Oberdorfer P, Borja-Tabora C, Bravo L, Carlos J, Tangsathapornpong A, Uppala R, Laoprasopwattana K, Yang Y, Han S, Wittawatmongkol O. Capeding MR, et al. Among authors: tangsathapornpong a. J Infect Dis. 2022 Aug 24;226(2):308-318. doi: 10.1093/infdis/jiaa770. J Infect Dis. 2022. PMID: 33351072 Free PMC article. Clinical Trial.
Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand.
Chotpitayasunondh T, Pruekprasert P, Puthanakit T, Pancharoen C, Tangsathapornpong A, Oberdorfer P, Kosalaraksa P, Prommalikit O, Tangkittithaworn S, Kerdpanich P, Techasaensiri C, Korejwo J, Chuenkitmongkol S, Houillon G. Chotpitayasunondh T, et al. Among authors: tangsathapornpong a. Vaccine. 2017 Jan 5;35(2):299-304. doi: 10.1016/j.vaccine.2016.11.062. Epub 2016 Nov 28. Vaccine. 2017. PMID: 27903416 Free article. Clinical Trial.
Immunogenicity and safety profiles of a new MAV/06 strain varicella vaccine in healthy children: A multinational, multicenter, randomized, double-blinded, active-controlled phase III study.
Choi UY, Kim KH, Lee J, Eun BW, Kim DH, Ma SH, Kim CS, Lapphra K, Tangsathapornpong A, Kosalaraksa P, Oberdorfer P, Kim HM, Shin SM, Kang JH. Choi UY, et al. Among authors: tangsathapornpong a. Vaccine. 2021 Mar 19;39(12):1758-1764. doi: 10.1016/j.vaccine.2021.02.013. Epub 2021 Feb 21. Vaccine. 2021. PMID: 33627245 Clinical Trial.
A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines.
Nanthapisal S, Puthanakit T, Jaru-Ampornpan P, Nantanee R, Sodsai P, Himananto O, Sophonphan J, Suchartlikitwong P, Hiransuthikul N, Angkasekwinai P, Tangsathapornpong A, Hirankarn N; study team. Nanthapisal S, et al. Among authors: tangsathapornpong a. Vaccine. 2022 Apr 20;40(18):2551-2560. doi: 10.1016/j.vaccine.2022.03.036. Epub 2022 Mar 24. Vaccine. 2022. PMID: 35341647 Free PMC article. Clinical Trial.
Development and validation of the predictive score for pediatric COVID-19 pneumonia: A nationwide, multicenter study.
Satdhabudha A, Chaiyakulsil C, Uppala R, Niyomkarn W, Tovichien P, Norasettekul V, Ruangnapa K, Smathakanee C, Choursamran B, Kulbun A, Jaroenying R, Kamalaporn H, Sriboonyong T, Roekworachai K, Sunkonkit K, Tangsathapornpong A, Bunjoungmanee P, Pao-In W, Thaweekul P, Tantiyavarong P, Ratanavongkosol T, Thongnual C, Sritipsukho P, Deerojanawong J. Satdhabudha A, et al. Among authors: tangsathapornpong a. PLoS One. 2022 Aug 29;17(8):e0273842. doi: 10.1371/journal.pone.0273842. eCollection 2022. PLoS One. 2022. PMID: 36037228 Free PMC article.
The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial.
Chantasrisawad N, Techasaensiri C, Kosalaraksa P, Phongsamart W, Tangsathapornpong A, Jaru-Ampornpan P, Sophonphan J, Suntarattiwong P, Puthanakit T; KIDSVAX study team. Chantasrisawad N, et al. Among authors: tangsathapornpong a. Int J Infect Dis. 2023 May;130:52-59. doi: 10.1016/j.ijid.2023.02.017. Epub 2023 Feb 24. Int J Infect Dis. 2023. PMID: 36841501 Free PMC article. Clinical Trial.
Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings.
Langley JM, Bianco V, Domachowske JB, Madhi SA, Stoszek SK, Zaman K, Bueso A, Ceballos A, Cousin L, D'Andrea U, Dieussaert I, Englund JA, Gandhi S, Gruselle O, Haars G, Jose L, Klein NP, Leach A, Maleux K, Nguyen TLA, Puthanakit T, Silas P, Tangsathapornpong A, Teeratakulpisarn J, Vesikari T, Cohen RA. Langley JM, et al. Among authors: tangsathapornpong a. J Infect Dis. 2022 Aug 26;226(3):374-385. doi: 10.1093/infdis/jiac227. J Infect Dis. 2022. PMID: 35668702 Free PMC article.
High seroprevalence of rubella in Thai children with a 2-dose MMR national immunization policy.
Angsuwatcharakon P, Puthanakit T, Bunjoungmanee P, Anugulruengkitt S, Srimuan P, Kowitdamrong E, Savangsindh P, Sophonphan J, Tantawichien T, Tangsathapornpong A. Angsuwatcharakon P, et al. Among authors: tangsathapornpong a. Vaccine. 2021 Oct 8;39(42):6206-6209. doi: 10.1016/j.vaccine.2021.08.079. Epub 2021 Sep 21. Vaccine. 2021. PMID: 34556367 Clinical Trial.
Seroprevalence of mumps among children and adolescents in Thailand, 2020.
Anugulruengkitt S, Angsuwatcharakon P, Puthanakit T, Bunjoungmanee P, Srimuan P, Kowitdamrong E, Sawangsinth P, Sophonphan J, Tantawichien T, Tangsathapornpong A. Anugulruengkitt S, et al. Among authors: tangsathapornpong a. Vaccine. 2022 Feb 16;40(8):1061-1064. doi: 10.1016/j.vaccine.2022.01.019. Epub 2022 Jan 22. Vaccine. 2022. PMID: 35078667
34 results